Slater and Gordon is looking to significantly expand its class action against National Australia Bank over the sale of “worthless” credit card insurance to include personal loan customers who were sold allegedly unsuitable insurance policies.
Promises to pay out claims under vehicle warranties issued by a unit of car leasing giant McMillan Shakespeare were illusory because of a clause that gave the company “manifestly sweeping” discretion to reject any claim, a judge has ruled, in a victory for a class action over the allegedly worthless financial products.
The Australian Competition and Consumer Commission will seek more than $4 million in refunds plus penalties when it takes the troubled operator of the Jump! Swim School franchise and its top executive to court for alleged violations of the Australian Consumer Law.
A settlement has been reached in a class action brought on behalf of individuals and businesses that allegedly suffered loss or injury from a 2017 fire at the Coolaroo recycling plant in Victoria.
Failed sandalwood oil producer Quintis has agreed to hand over insurance policies showing any coverage for potential liability it or its former CEO may have in two class actions brought against them.
The long-running dispute between Kraft Foods and Bega over who owns the rights to use the signature Kraft peanut butter trade dress in Australia is not over, with Kraft appealing a ruling that found Bega had acquired the rights to the trade dress when it purchased Kraft unit Mondelez’s Australian and New Zealand business in 2017.
The Fair Work Commission has dismissed an appeal by the Construction, Forestry, Maritime, Mining and Energy Union challenging a decision by a commissioner to not recuse herself from hearing a construction site dispute with Watpac after commenting that the union’s complaint about safety concerns at the site appeared to be a āsmokebombā.
NSW Ports is facing a new lawsuit over an allegedly anti-competitive agreement entered into with the NSW state government for the privatisation of Port Botany and Port Kembla, which is the subject of a separate case brought by the competition regulator.
The former chief financial officer of a unit of collapsed Gold Coast finance company Octaviar Investments is facing fraud charges for allegedly misappropriating more than $4.6 million in company funds for his personal use.
Novartis has launched an appeal following a ruling by IP Australia that a proposed patent for an oral form of its top-selling multiple sclerosis drug Gilenya is invalid for lack of inventive step.